Clinical Research is Thriving in Brazil

In 2008, the cost per patient for trials in Brazil was approximately 30% less than the cost in the United States of America. More importantly, Brazil enjoys a major advantage in recruiting patients for Oncology, CNS, Cardiovascular Disease, and Diabetes. Because of this, Brazil is expected to receive a large and increasing share of the clinical trials conducted outside the United States of America.

Thanks to ethnic diversity, heterogeneous epidemiological profiles  and a willingness to participate in clinical trial programs due to lack of access, Brazil is a tremendously attractive market for clinical research.  Add to that its expected market growth rate of approximately 12% for 2009 and you have an emerging country with the potential to contribute large numbers of patients eager to participate in clinical research in a market that is expected to outpace growth in the USA by almost 10%.

Sponsors from around the world recognize the importance of the Brazilian market and the growing opportunity to conduct studies within Brazil.
 

Capacity and Diversity

Brazil is the 5th most populous country in the world and growing, with an estimated 190 million people. Eighty percent of these people are located in close proximity to a large metropolitan area making it easy for them to gain access to a clinical trial. The Brazilian population is also very diverse, including both young and old.  It is estimated that 25% of the population is under the age of 14, making it an excellent location for pediatric trials. 

Brazil has the largest ethnic Japanese population outside Japan and data from studies conducted in Brazil are acceptable to the Japanese Ministry of Health making Brazil an excellent location for bridging studies.  Brazil also has a high incidence of certain rare and tropical diseases allowing for research in such areas as dengue fever and malaria.

Because of the interest in receiving the best possible medical care at affordable prices, patients are eager to participate in clinical trials and Eurotrials’ patient retention rate is consistently above 90%.
 

Qualified Professionals

The multi-lingual Brazilian team boasts different skill sets and diverse backgrounds, allowing for a unique group of professionals with a broad knowledge and experience base.

• 4 MDs
• 18 Clinical Staff
• 5 Regulatory Affairs Staff
• 1 Export / Import  Associate
• 1 Business Development Manager

Because of Eurotrials’ experience and expertise we are able to undertake and successfully develop any step of the clinical research process.